Guideline-recommended therapies for hospitalized heart failure patients in China show large gaps in effective application, with coronary heart disease and hypertension being the most prevalent causes.
Observational
There remain significant gaps in the real-world application of guideline-recommended therapies for hospitalized heart failure patients in China.
Among the hospitalized patients with HF in China, coronary heart disease and hypertension are the mostly prevalent causes. HFpEF accounts for a large proportion of hospitalized patients with HF. HFrEF, HFmrEF and HFpEF have different etiology and clinical features. In real-world, there are still large gaps in the effective application of the guideline recommended therapies to HF patients, especially the non-pharmacological therapy option, which needs to be improved further in China.
Wang et al. (Sun,) conducted a observational in Heart failure. Guideline-recommended therapies was evaluated. Guideline-recommended therapies for hospitalized heart failure patients in China show large gaps in effective application, with coronary heart disease and hypertension being the most prevalent causes.